Ignite Creation Date:
2024-05-06 @ 4:26 PM
Last Modification Date:
2024-10-26 @ 2:10 PM
Study NCT ID:
NCT04989322
Status:
RECRUITING
Last Update Posted:
2021-12-08
First Post:
2021-07-26
Brief Title:
Pembrolizumab Lenvatinib and Chemotherapy After TKIs in NSCLC
Sponsor:
Dr Joanne CHIU
Organization:
The University of Hong Kong
Conditions & Keywords Data
Conditions:
| Name |
|---|
| ROS1 Positive NSCLC - Reactive Oxygen Species 1 Positive Non-Small Cell Lung Cancer |
| Nsclc |
| EGFR Activating Mutation |
| EGF-R Positive Non-Small Cell Lung Cancer |
| ALK Gene Rearrangement Positive |
| ROS1 Gene Rearrangement |
Keywords: